<DOC>
	<DOCNO>NCT00152815</DOCNO>
	<brief_summary>The purpose study evaluate effect one-year nutritional intervention either betaine vitamin E supplementation , weight reduce diet exercise program liver steatosis steatohepatitis .</brief_summary>
	<brief_title>Non-alcoholic Fatty Liver Disease ( NAFLD ) HIV : The Role Nutritional Interventions</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Baseline liver biopsy macrovesicular fatty degeneration inflammation ( lobular portal ) , without Mallory body , hepatocyte damage , and/or fibrosis diagnostic NAFLD Convincing evidence negligible alcohol consumption ( &lt; 20 gram ethanol per day ) obtain detailed history , confirm least one close relative If hyperlipidemia diabetes , stable drug regimen require 6 month prior study Willingness maintain stable weight normal exercise program duration study , randomize vitamin E betaine Liver disease etiology diagnose per routine medical investigation ( e.g. , chronic viral hepatitis , autoimmune chronic hepatitis , primary biliary cirrhosis genetic liver disease Wilson 's disease , hemochromatosis , alpha1 antitrypsin deficiency , biliary obstruction ) Complications liver disease recurrent variceal bleeding , resistant ascites , spontaneous portosystemic encephalopathy , bacterial peritonitis Concurrent medical illness contraindicate liver biopsy , history unexplained bleeding , hemophilia abnormal coagulation result per routine laboratory workup reason judge hepatologist contraindicate percutaneous liver biopsy Medications know precipitate steatohepatitis ( corticosteroid , high dose estrogen , methotrexate , amiodarone , calcium channel blocker , spironolactone , sulfasalazine , naproxen , oxacillin ampinovire ) 6 month prior entry Antioxidant vitamin supplementation , ursodeoxycholic acid , experimental drug 6 month prior study entry Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>non-alcoholic fatty liver disease</keyword>
</DOC>